A. Uzilov

发表

JBrowse: a next-generation genome browser.

L. Stein, C. Mungall, I. Holmes, 2009, Genome research.

FragSeq: transcriptome-wide RNA structure probing using high-throughput sequencing

D. Haussler, D. Mathews, J. Underwood, 2010, Nature Methods.

Evolutionary Modeling and Prediction of Non-Coding RNAs in Drosophila

Ian Holmes, Lars Barquist, Yuri R. Bendaña, 2009, PloS one.

A new molecular signature method for prediction of driver cancer pathways from transcriptional data

E. Schadt, B. Reva, A. Uzilov, 2016, Nucleic acids research.

Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas

M. Mahajan, E. Schadt, B. Reva, 2017, Nature Communications.

Disease-associated variants in different categories of disease located in distinct regulatory elements

Jörg Hakenberg, Wei-Yi Cheng, Benjamin S Glicksberg, 2015, BMC Genomics.

Methylation guide RNA evolution in archaea: structure, function and genomic organization of 110 C/D box sRNA families across six Pyrobaculum species

T. Lowe, P. Dennis, A. Uzilov, 2018, Nucleic acids research.

Assessment of somatic single-nucleotide variation in brain tissue of cases with schizophrenia

V. Haroutunian, A. Uzilov, P. Roussos, 2019, Translational Psychiatry.

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

G. Sonpavde, W. Oh, M. Galsky, 2022, The oncologist.

Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach

Li Li, Brian A. Kidd, Joel T. Dudley, 2017, Scientific Reports.

Genomic profiling reveals mutational landscape in parathyroid carcinomas.

E. Schadt, Yevgeniy Antipin, R. Sebra, 2017, JCI insight.

TITLE PAGE Title: Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma. Running title: Novel RASD1 mutation in a corticotroph adenoma

M. Mahajan, E. Schadt, R. Sebra, 2017 .

Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma

M. Mahajan, E. Schadt, R. Sebra, 2017, Cold Spring Harbor molecular case studies.

CNA Explorer and anaLyzer (CNAEL): an interactive web application and standard operating procedure enabling efficient clinical review and reporting of complex NGS-derived tumor copy number profiles

L. Lochovsky, A. Uzilov, A. Silkov, 2022, medRxiv.

Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

Richard L. Halpert, R. Sebra, Rileen Sinha, 2016, Clinical Cancer Research.

Detection of non-coding RNAs on the basis of predicted secondary structure formation free energy change

David H. Mathews, Andrew V. Uzilov, Joshua M. Keegan, 2006, BMC Bioinformatics.

XRate: a fast prototyping, training and annotation tool for phylo-grammars

Ian Holmes, Carolin Kosiol, Nick Goldman, 2006, BMC Bioinformatics.

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.

E. Schadt, G. Sonpavde, W. Oh, 2017, European urology.

Development and clinical application of an integrative genomic approach to personalized cancer therapy

Benjamin S. Glicksberg, Gintaras Deikus, Imane Bourzgui, 2016, Genome Medicine.

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

Elena Pereira, Robert Sebra, Navya Nair, 2015, PloS one.

USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors.

M. Mahajan, R. Sebra, Rong Chen, 2020, The Journal of clinical endocrinology and metabolism.

Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

P. Schirmacher, S. Friedman, P. Boffetta, 2021, Journal of hepatology.

Parafibromin Abnormalities in Ossifying Fibroma

R. Sebra, Rong Chen, A. Uzilov, 2021, Journal of the Endocrine Society.

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

E. Schadt, Yevgeniy Antipin, R. Sebra, 2019, Science Advances.

High-Throughput Nuclease Probing of RNA Structures Using FragSeq.

Jason G. Underwood, Andrew V. Uzilov, J. Underwood, 2016, Methods in molecular biology.

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

V. Mazzaferro, S. Friedman, J. Llovet, 2022, Gut.

A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma

E. Schadt, Yevgeniy Antipin, R. Sebra, 2021, iScience.

Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas

M. Mahajan, E. Schadt, B. Reva, 2017, Nature Communications.

Aberrant methylation underlies insulin gene expression in human insulinoma

E. Schadt, Yevgeniy Antipin, L. Lambertini, 2020, Nature Communications.

Response to Letter to the Editor from Lasolle and Raverot: “USP8 and TP53 Drivers Are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors”

A. Uzilov, E. Geer, 2021, The Journal of clinical endocrinology and metabolism.

Integrated genomic analysis by whole exome and transcriptome sequencing of tumor samples from EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p) with acquired resistance to erlotinib.

J. Weissman, R. Stahel, A. Uzilov, 2013 .

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

R. Sebra, M. Galsky, R. Halperin, 2023, Journal for ImmunoTherapy of Cancer.

Integrating 400 million variants from 80,000 human samples with extensive annotations: towards a knowledge base to analyze disease cohorts

Rong Chen, Jörg Hakenberg, Philippe Thomas, 2016, BMC Bioinformatics.

FragSeq: transcriptome-wide RNA structure probing using high-throughput sequencing

D. Haussler, D. Mathews, J. Underwood, 2010, Nature Methods.